CM
BHVN

Caption Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Caption Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-91,500
Closed -$11.7M – 2013
2022
Q1 		$10.8M Buy
91,500
+71,500
+358% +$8.92M 0.13% 195
2021
Q4 		$2.76M Sell
20,000
-64,700
-76% -$8.23M 0.03% 671
2021
Q3 		$11.8M Buy
84,700
+76,200
+896% +$9.51M 0.13% 198
2021
Q2 		$825K Sell
8,500
-4,100
-33% -$333K 0.01% 945
2021
Q1 		$861K Sell
12,600
-242,006
-95% -$19.6M 0.02% 712
2020
Q4 		$21.8M Buy
254,606
+121,606
+91% +$10.3M 0.5% 38
2020
Q3 		$8.65M Buy
133,000
+77,684
+140% +$5.09M 0.2% 115
2020
Q2 		$4.04M Buy
55,316
+33,464
+153% +$1.78M 0.13% 203
2020
Q1 		$745K Sell
21,852
-147,148
-87% -$6.73M 0.04% 472
2019
Q4 		$9.2M Sell
169,000
-99,900
-37% -$4.95M 0.31% 73
2019
Q3 		$11.2M Buy
+268,900
New +$11.4M 0.58% 36
2019
Q2 		– Sell
-123,400
Closed -$6.96M – 933
2019
Q1 		$6.35M Buy
+123,400
New +$5.33M 0.35% 80

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Caption Management's BHVN Position: Q2 2022 in Review

Caption Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 91,500 shares — an estimated $11.7M sold.

Caption Management first reported a position in BHVN in Q1 2019 and held it in 12 quarters. The position peaked at $21.8M in Q4 2020. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • Caption Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • Caption Management sold 91,500 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $11.7M.
  • Caption Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 12 quarters.
  • Caption Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $21.8M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.